{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:41:38Z","timestamp":1777664498918,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T00:00:00Z","timestamp":1562371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00296-019-04370-0","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T08:03:43Z","timestamp":1562400223000},"page":"1883-1887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8082-1009","authenticated-orcid":false,"given":"Keita","family":"Ninagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-6585","authenticated-orcid":false,"given":"Masaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-7573","authenticated-orcid":false,"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-1007","authenticated-orcid":false,"given":"Nobuya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-534X","authenticated-orcid":false,"given":"Michihito","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4705-341X","authenticated-orcid":false,"given":"Yuichiro","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-665X","authenticated-orcid":false,"given":"Kenji","family":"Oku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-2077","authenticated-orcid":false,"given":"Shinsuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-1765","authenticated-orcid":false,"given":"Hiroshi","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0196-9572","authenticated-orcid":false,"given":"Ichizo","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5657-962X","authenticated-orcid":false,"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,6]]},"reference":[{"issue":"10","key":"4370_CR1","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u20131815","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4370_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13075-017-1341-x","volume":"19","author":"K Morrisroe","year":"2017","unstructured":"Morrisroe K, Stevens W, Huq M, Prior D, Sahhar J, Ngian GS et al (2017) Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Res Ther 19(1):122","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4370_CR3","doi-asserted-by":"publisher","first-page":"e12876","DOI":"10.1111\/eci.12876","volume":"48","author":"M Kato","year":"2018","unstructured":"Kato M, Atsumi T (2018) Pulmonary arterial hypertension associated with connective tissue diseases: a review focusing on distinctive clinical aspects. Eur J Clin Invest 48(2):e12876","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"4370_CR4","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D et al (2014) Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 73(7):1340\u20131349","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4370_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13075-017-1327-8","volume":"19","author":"A Guillen-Del Castillo","year":"2017","unstructured":"Guillen-Del Castillo A, Callejas-Moraga EL, Garcia G, Rodriguez-Palomares JF, Roman A, Berastegui C et al (2017) High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center. Arthritis Res Ther 19(1):135","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4370_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.02275-2016","volume":"49","author":"E Vandecasteele","year":"2017","unstructured":"Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E et al (2017) Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort. Eur Respir J 49(5):1\u20139","journal-title":"Eur Respir J"},{"issue":"4","key":"4370_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.37838","volume":"65","author":"CJ Valerio","year":"2013","unstructured":"Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG (2013) Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 65(4):1074\u20131084","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4370_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53(1):1\u201313","journal-title":"Eur Respir J"},{"issue":"8","key":"4370_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/annrheumdis-2011-200546","volume":"71","author":"S Bae","year":"2012","unstructured":"Bae S, Saggar R, Bolster MB, Chung L, Csuka ME, Derk C et al (2012) Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis 71(8):1335\u20131342","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4370_CR10","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.30541","volume":"63","author":"M Humbert","year":"2011","unstructured":"Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D et al (2011) Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 63(11):3522\u20133530","journal-title":"Arthritis Rheum"},{"issue":"20","key":"4370_CR11","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"N Galie","year":"2009","unstructured":"Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30(20):2493\u20132537","journal-title":"Eur Heart J"},{"issue":"3","key":"4370_CR12","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar3876","volume":"14","author":"V Thakkar","year":"2012","unstructured":"Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D et al (2012) N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther 14(3):R143","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"4370_CR13","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/art.38172","volume":"65","author":"D Khanna","year":"2013","unstructured":"Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE et al (2013) Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 65(12):3194\u20133201","journal-title":"Arthritis Rheum"},{"key":"4370_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-015-0517-5","volume":"17","author":"Y Hao","year":"2015","unstructured":"Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C et al (2015) A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Res Ther 17:7","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4370_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/art.39432","volume":"68","author":"V Sobanski","year":"2016","unstructured":"Sobanski V, Giovannelli J, Lynch BM, Schreiber BE, Nihtyanova SI, Harvey J et al (2016) Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheumatol 68(2):484\u2013493","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04370-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04370-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04370-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T07:17:31Z","timestamp":1603178251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04370-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,6]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4370"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04370-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,6]]},"assertion":[{"value":"9 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No specific funding was received to carry out the work described in this manuscript. TA reports personal fees from Chugai, during the conduct of the study; grants and personal fees from Astellas, grants and personal fees from Takeda, grants and personal fees from Mitsubishi Tanabe, grants and personal fees from Chugai, grants and personal fees from Pfizer, grants from Daiichi Sankyo, grants from Otsuka, personal fees from Eisai, and personal fees from AbbVie, outside the submitted work. SY reports grants and speaker\u2019s fee from Bristol-Myers Squibb Co., Speaker\u2019s fee from Chugai, Mitsubishi Tanabe, outside the submitted work. MK reports grants from GSK, grants from Actelion, outside the submitted work. The other authors state that they have no conflict of interest. TA reports personal fees from Chugai, during the conduct of the study; grants and personal fees from Astellas, grants and personal fees from Takeda, grants and personal fees from Mitsubishi Tanabe, grants and personal fees from Chugai, grants and personal fees from Pfizer, grants from Daiichi Sankyo, grants from Otsuka, personal fees from Eisai, and personal fees from AbbVie, outside the submitted work. SY reports grants and speaker\u2019s fee from Bristol-Myers Squibb Co., Speaker\u2019s fee from Chugai, Mitsubishi Tanabe, outside the submitted work. MK reports grants from GSK, grants from Actelion, outside the submitted work. The other authors state that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}